Interleukin‐6‐mediated resistance to immunotherapy is linked to impaired myeloid cell function

High serum levels of interleukin‐6 (IL‐6) correlate with poor prognosis and chemotherapy resistance in several cancers. The underlying mechanisms and its effects on immunotherapy are largely unknown. To address this, we developed a human papillomavirus type 16 (HPV16)‐associated tumor model expressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Beyranvand Nejad, Elham, Labrie, Camilla, van der Sluis, Tetje C., van Duikeren, Suzanne, Franken, Kees L. M. C., Roosenhoff, Rueshandra, Arens, Ramon, van Hall, Thorbald, van der Burg, Sjoerd H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Tumor Immunology and Microenvironment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693233/
https://www.ncbi.nlm.nih.gov/pubmed/32875568
http://dx.doi.org/10.1002/ijc.33280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693233/
https://www.ncbi.nlm.nih.gov/pubmed/32875568
http://dx.doi.org/10.1002/ijc.33280

Ejemplares similares